Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability
Author:
Odorisio Teresa1, Schietroma Cataldo1, Zaccaria M. Letizia1, Cianfarani Francesca1, Tiveron Cecilia2, Tatangelo Laura2, Failla Cristina M.1, Zambruno Giovanna1
Affiliation:
1. Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IRCCS, 00167 Rome, Italy 2. Transgenic Mice Service Center, Istituto Regina Elena, IRCCS, 00158 Rome,Italy
Abstract
Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family, comprising at least five cytokines specifically involved in the regulation of vascular and/or lymphatic endothelium differentiation. Several lines of evidence indicate a role for PlGF in monocyte chemotaxis and in potentiating the activity of VEGF, but the exact function of this cytokine is not fully understood. To define the biological role of PlGF in vivo, we have produced a transgenic mouse model overexpressing this factor in the skin by using a keratin 14 promoter cassette. Our data indicate that PlGF has strong angiogenic properties in both fetal and adult life. PlGF overexpression results in a substantial increase in the number,branching and size of dermal blood vessels as well as in enhanced vascular permeability. Indeed, intradermally injected recombinant PlGF was able to induce vessel permeability in wild-type mice. The analysis of vascular endothelial growth factor receptor 1/flt-1 and vascular endothelial growth factor receptor 2/flk-1 indicates that the two receptors are induced in the skin endothelium of transgenic mice suggesting that both are involved in mediating the effect of overexpressed PlGF.
Publisher
The Company of Biologists
Reference41 articles.
1. Cao, Y., Chen, H., Zhou, L., Chiang, M. K., Anand-Apte, B.,Wheatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G. and Tsang, M. L.(1996). Heterodimers of placenta growth factor/vascular endothelial growth factor. J. Biol. Chem.271, 3154-3162. 2. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med.6, 389-395. 3. Carmeliet, P. and Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature407, 249-257. 4. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S.,Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K.,Eberhardt, C. et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.Nature380, 435-439. 5. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle,V., de Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H. et al.(2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med.7, 575-583.
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|